The treatment of pelvic inflammatory disease.
The treatment of pelvic inflammatory disease depends upon the etiology of the condition. Pelvic infection (PI) after parturition and abortion, gynecologic surgery, and a variety of invasive procedures is commonly associated with the isolation of anaerobic and aerobic flora of the vagina. The factors which influence the choice of antimicrobial treatment and the role of Bacteroides fragilis and Escherichia coli are discussed. Sexually transmissible agents of importance are Neisseria gonorrhoeae and Chlamydia trachomatis. Pelvic infections associated with these pathogens require antibiotics which exert an optimum effect against them. Examination and treatment of the sexual partner(s) are important. The possible role of the anaerobic and aerobic vaginal flora as opportunistic secondary pathogens is discussed. Developments in the surgical treatment of the sequelae of PID are reviewed. The results of treatment of uncomplicated gonorrhea in 262 women are reported. C. trachomatis was isolated from 53% of women before treatment. After treatment, PI developed in 11 women who had been given penicillin and in one woman who had been given tetracycline (P = 0.0071). It is suggested that recognition and treatment of postgonococcal cervicitis in women treated for uncomplicated gonorrhea with penicillin might provide one form of preventive treatment for nongonococcal PI.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D005260:Female; D005831:Genital Diseases, Female / Q000601:surgery; D006069:Gonorrhea; D006801:Humans; D008219:Lymphogranuloma Venereum; D000292:Pelvic Inflammatory Disease / Q000188:drug therapy / Q000209:etiology / Q000601:surgery / Q000628:therapy*; D011183:Postoperative Complications; D011247:Pregnancy; D012749:Sexually Transmitted Diseases / Q000150:complications
D000900:Anti-Bacterial Agents